Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

• Date:
  Monday, 5 February 2024, All day
  Thursday, 8 February 2024, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the PRAC meeting 5-8 February 2024

Draft Reference Number: EMA/PRAC/11237/2024 Corr.1

Minutes of the PRAC meeting 5-8 February 2024

Adopted Reference Number: EMA/PRAC/122241/2024